Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02483559 · ClinicalTrials.gov registry record · NA
Seeing the World Through Assorted Glasses
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02483559 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 15 participants.
The verdict
NCT02483559, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of the study is to test the use of amber glasses at night as a method to block blue light from the eye, allowing the brain to produce a dim-light melatonin onset. The investigators hypothesize that blue-blocking will produce measurable benefits in subjectively and objectively rated sleep quality and mood as well as salivary melatonin levels during the night.
Interventions
- OTHER Amber Lenses
- OTHER Placebo Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02483559
The ClinicalTrials.gov registry entry for NCT02483559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amber Lenses is the first listed.
NCT02483559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02483559 about?
NCT02483559 is a clinical study titled "Seeing the World Through Assorted Glasses". The purpose of the study is to test the use of amber glasses at night as a method to block blue light from the eye, allowing the brain to produce a dim-light melatonin onset. The investigators hypothesize that blue-blocking will produce measurable benefits in subjectively and objectively rated sleep...
What is the current status of trial NCT02483559?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2015-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02483559?
The interventions under investigation include: Amber Lenses (OTHER), Placebo Lenses (OTHER).
Who is sponsoring clinical trial NCT02483559?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.